查詢結果分析
相關文獻
- 多葉準直儀系統性誤差對於VMAT劑量分佈的影響分析
- Comprehensive Measurement for Clinical Dosimetry of Tertiary Multileaf Collimator
- Elekta直線加速器多葉準直儀舌槽效應之測量與研究
- Elekta直線加速器多葉準直儀舌槽效應補償器之研製
- 前列腺癌影像導引放射治療擺位誤差之劑量評估
- 應用EBT3自顯底片執行Varian Millennium 120-leaf多葉準直儀的品質保證作業
- 使用EPIQA系統評估滑窗式與分段式多葉準直儀之優劣
- An Effective Method to Eliminate the Multileaf Collimator Tongue and Groove Underdosage
- 放射線強度調控治療上呼吸運動修正的可行性研究
- 比較共平面與非共平面體積調控弧形治療技術用於肝門靜脈血栓之肝癌放射治療計畫劑量評估
頁籤選單縮合
題名 | 多葉準直儀系統性誤差對於VMAT劑量分佈的影響分析=Effect of Systematic MLC Errors on the VMAT Technique in the Dose Distribution |
---|---|
作者姓名(中文) | 張智傑; 蕭安成; 蔡若婷; | 書刊名 | 放射治療與腫瘤學 |
卷期 | 24:2 2017.06[民106.06] |
頁次 | 頁129-140 |
分類號 | 416.36 |
關鍵詞 | 體積調控弧形治療; 多葉準直儀; 加馬指標分析; 等效均勻劑量; Volumetric-modulation arc therapy; VMAT; Multileaf collimator; MLC; Gamma index analysis; Equivalent uniform dose; |
語文 | 中文(Chinese) |
中文摘要 | 目的:了解多葉準直儀(MLC)系統性誤差對於體積調控弧形治療(VMAT)在劑量分佈和生物劑量參數的影響。材料與方法:以AAPM TG-119報告為依據,本研究製作了五個VMAT治療計畫(多顆腫瘤、攝護腺腫瘤、頭部腫瘤、寬鬆C形腫瘤以及嚴格C形腫瘤)。各治療計畫中加入兩個方向(+ open, - close)四種程度的系統性誤差值(±0.5 mm, ±1 mm, ±2 mm, ±3 mm)。分別以各計畫在分析閾值為3%/3 mm與2%/2 mm的加馬指標分析(gamma index analysis)結果及靶體積和危急器官的等效均勻劑量(equivalent uniform dose)計算結果來評估MLC系統性誤差對於劑量分佈和生物劑量參數的影響程度。結果:每單位MLC系統性誤差(mm)在open方向對於加馬指標分析閾值在3 mm/3%和2 mm/2%的結果影響分別為-11.69%及-18.44%,而在close方向則分別為-9.73%和-15.30%。若要達成90%以上的加馬指標通過率,在閾值為3 mm/3%和2 mm/2%時可允許的誤差容許值在open方向分別為0.86 mm及0.54 mm,而在close方向則分別為1.03 mm和0.65 mm。每單位MLC系統性誤差(mm)對於靶體積及危急器官EUD的差異百分比分別為6.30%和5.20%。結論:本研究建議的MLC系統性誤差容許值為1 mm,和TG 142的建議相同。放射治療中心需具有完善的MLC品質保證計畫,以確保病患獲得正確的處方劑量及避免嚴重的併發症產生。 |
英文摘要 | Purpose: The purpose of this study was to understand the consequence of MLC systematic errors on the VMAT technique in the dose distribution. Material and Methods: Five VMAT treatment plans (multiTumor, Prostate, Head, C_loose_plan, and C_strict_plan) followed TG-119 instructions were created. MLC systematic errors were simulated for error magnitudes of ±0.5 mm, ±1 mm, ±2 mm, and ±3 mm in X1 bank (+ open, - close). The 3 mm/3% and 2 mm/2% gamma index analysis and PTVs and OARs equivalent uniform dose (EUD) were used to evaluate the impact of MLC systematic errors on the dose distribution and the biological dose parameter. Materials and Methods: In total 97 patients with breast cancer were included, they were treated with hybrid intensity-modulated radiotherapy (Hybrid IMRT) for 50.4 Gy in 28 fractions. Patients were evaluated at three months after treatment through the observation of the change of chest computed tomography image. The final endpoint of complication was according to Arriagada's classification. Patients with grade 1+ change on CT images were defined as a complication of radiation pneumonitis. We evaluated the correlation of radiation pneumonitis and mean ipsilateral lung dose. We established LKB NTCP model through calculated the equivalent uniform dose (EUD) of ipsilateral lung and validated the model performance. The NTCP model was mainly used to investigate the dose-response curve for complications of radiation pneumonitis and provided dose parameters to prevent complication of endemic breast cancer patients. Result: The average 3 mm/3% and 2 mm/2% gamma index passing rate was decreased by 11.69% per mm and 18.44% per mm in the open direction and 9.73% per mm and 15.30% per mm in the close direction. The tolerance of MLC systematic errors to achieve > 90% criteria for 3%/3 mm and 2 mm/2% gamma analysis was 0.86 mm and 0.54 mm in the open direction and 1.03 mm and 0.65 mm in the close direction. The impact of average EUD difference on PTVs and OARs was 6.30% per mm and 5.20% per mm. Conclusion: The present study suggested that the tolerance of systemic MLC errors was 1mm. Radiation treatment centers should have adequate MLC quality assurance program to ensure clinical outcomes and avoid serious complications. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。